Sign Up Today and Learn More About LaNova Medicines Stock
Invest in or calculate the value of your shares in LaNova Medicines or other pre-IPO companies through EquityZen's platform.
LaNova Medicines Stock (LAME)
LaNova Medicines is a clinical-stage innovative drug research and development company.
About LaNova Medicines Stock
Founded
2019
Industries
Software, Artificial Intelligence, Data and Analytics
LaNova Medicines Press Mentions
Stay in the know about the latest news on LaNova Medicines
Why This Beaten-Down Stock Is a Buy in 2025 and Beyond
fool • Jan 27, 2025
GI Innovation-LaNova Medicines Signs MOU for GI-102 + ADC Pancreatic Cancer Combination Therapy
biospace • Jan 23, 2025
GI Innovation-LaNova Medicines Signs MOU for GI-102 + ADC Pancreatic Cancer Combination Therapy
en • Jan 22, 2025
GI Innovation-LaNova Medicines Signs MOU for GI-102 + ADC Pancreatic Cancer Combination Therapy
prnewswire • Jan 22, 2025
Merck closes exclusive global license agreement for LM-299 from LaNova Medicines
finance • Dec 28, 2024
Join now and verify your accreditation status to gain access to:
- LaNova Medicines Current Valuation
- LaNova Medicines Stock Price
- LaNova Medicines Management
- Available deals in LaNova Medicines and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- LaNova Medicines Cap Table and Funding History by Share Class and Liquidity Preferences
- LaNova Medicines Revenue and Financials
- LaNova Medicines Highlights
- LaNova Medicines Business Model
- LaNova Medicines Risk Factors
- LaNova Medicines Research Report from SACRA Research
Trading LaNova Medicines Stock
How to invest in LaNova Medicines stock?
Accredited investors can buy pre-IPO stock in companies like LaNova Medicines through EquityZen funds. These investments are made available by existing LaNova Medicines shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell LaNova Medicines stock?
Shareholders can sell their LaNova Medicines stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
